Therapy of Niacin for Rheumatoid Arthritis

This study is a study to evaluate the safety and efficacy of administering niacin sustained-release capsules to rheumatoid arthritis with hyperlipidemia patients. Sixty patients were randomly assigned to niacin or placebo for 12 weeks, followed by niacin for 12 weeks. Changes in disease activity score, immune cell subtypes, markers of intestinal damage, intestinal flora, and other laboratory indicators will be monitored.

NCT Number	NCT07004725
Lead Sponsor	Peking University People's Hospital
Conditions	Rheumatoid Arthritis (RA)
Enrollment	60 participants
Start Date	2025-05-28
Primary Completion	2027-01-03 (estimated)
Study Completion	2027-06-15 (estimated)
Updated on ClinicalTrials.gov	2025-06-04